Optimizing BeLPT criteria for beryllium sensitization

American Journal of Industrial Medicine

Volumn 51, Issue 3, 2008, Pages 166-172

  Middleton, D C ^a   Fink, J ^a   Kowalski, P J ^a   Lewin, M D ^a   Sinks, T ^a  

^a AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY   (United States)

Author keywords

Algorithm; Berylliosis; Beryllium; Beryllium lymphocyte proliferation test (BeLPT); Chronic beryllium disease; Positive predictive value; Proliferation; Sarcoidosis; Sensitivity; Sensitization; Specificity

Indexed keywords

BERYLLIUM;

ARTICLE; BERYLLIUM LYMPHOCYTE PROLIFERATION TEST; CONTROLLED STUDY; FALSE POSITIVE RESULT; HUMAN; LABORATORY TEST; OUTCOME ASSESSMENT; PREDICTION; PREVALENCE; PROBABILITY; SENSITIVITY AND SPECIFICITY; SENSITIZATION;

ALGORITHMS; BERYLLIOSIS; BERYLLIUM; CELL PROLIFERATION; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); HUMANS; INTERPROFESSIONAL RELATIONS; LIKELIHOOD FUNCTIONS; LYMPHOCYTE ACTIVATION; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROBABILITY; SENSITIVITY AND SPECIFICITY; UNITED STATES;

EID: 39449094512     PISSN: 02713586     EISSN: 10970274     Source Type: Journal    
DOI: 10.1002/ajim.20548     Document Type: Article

References (11)

1. (ATSDR) Agency for Toxic Substances and Disease Registry. 2006. Health Consultation concerning former American Beryllium Site Tallevast, Manatee County, Florida. EPA Facility Id: Fld004100731. Atlanta: US Department of Health and Human Services. Available at: http://www.atsdr.cdc.gov/HAC/PHA/ Former%20American%20Beryllium%20Site/FormerAmericanBerylliumEI032006.pdf (Accessed 25 June 2007).
2. Borak J, Woolf SH, Fields CA. 2006. Use of beryllium lymphocyte proliferation testing for screening of asymptomatic individuals: An evidence-based assessment. J Occup Environ Med 48(9):937-947.
3. Deubner DC, Goodman M, Iannuzzi J. 2001. Variability, predictive value, and uses of the beryllium blood lymphocyte proliferation test (BLPT): Preliminary analysis of the ongoing workforce survey. Appl Occup Environ Hyg 16(5):521-526.
4. Fleiss JL, Levin B, Paik MC. 2003. Statistical methods for rates and proportions. 3rd ed. New York: John Wiley & Sons.
5. Kreiss K, Day GA, Schuler CR. 2007. Beryllium: A modern industrial hazard. Annu Rev Public Health 28:259-277.
6. Middleton DC. 1998. Chronic beryllium disease: Uncommon disease, less common diagnosis. Environ Health Perspect 106:765-767.
7. Middleton DC, Lewin MD, Kowalski PJ, Cox SS, Kleinbaum D. 2006. The BeLPT: Algorithms and implications. Am J Ind Med 49:36-44.
8. Müller-Quernheim J, Gaede KI, Fireman E, Zissel G. 2006. Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients. Eur Respir J 27(6):1190-1195.
9. Newman LS, Kreiss K. 1992. Nonoccupational beryllium disease masquerading as sarcoidosis: Identification by blood lymphocyte proliferative response to beryllium. Am Rev Respir Dis 145:1212.
10. Stange AW, Furman FJ, Hilmas DE. 2004. The beryllium lymphocyte proliferation test: Relevant issues in beryllium health surveillance. Am J Ind Med 46:453-462.
11. Welch L, Ringen K, Bingham E, Dement J, Takaro T, McGowan W, Chen A, Quinn P. 2004. Screening for beryllium disease among construction trade workers at Department of Energy nuclear sites. Am J Ind Med 46:207-218.